Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

News: Coronavirus can be contagious during a... (CNN News) - Behind the headlines

In the news

Media coverage of health and science topics

CNN News May 31, 2022

Coronavirus can be contagious during a Paxlovid rebound, researchers warn, even if people don't have symptoms

People experiencing a Covid-19 rebound after treatment with the antiviral drug Paxlovid can be contagious, and researchers are warning that they may not know it because they might not have any symptoms when they are.

Read more at CNN News

Behind the headlines

Research findings and data from the National Library of Medicine

PubMed articles

N Engl J Med APRIL 14, 2022

Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19

J Hammond et al

Treatment of symptomatic Covid-19 with nirmatrelvir plus ritonavir resulted in a risk of progression to severe Covid-19 that was 89% lower than the risk with placebo, wit …

Related content

Similar articles

Reviews

People also viewed

Also of interest

Additional recent and related news

CNN News JULY 30, 2022

Coronavirus can be contagious during a Paxlovid rebound, researchers warn, even if people don't have symptoms | CNN

People experiencing a Covid-19 rebound after treatment with the antiviral drug Paxlovid can be contagious, and researchers are warning that they may not know it because they might not have any symptoms when they are.

The Scientist MAY 20, 2022

What’s the Evidence for Fluvoxamine in COVID-19? 

The US FDA’s decision not to grant an emergency use authorization for the antidepressant as a COVID-19 treatment highlights a lack of consensus among researchers about how to interpret clinical data on the drug.

CNN News NOV. 16, 2022

Covid-19 rebound may be more common in people who take Paxlovid, early study suggests | CNN

Cases of Covid-19 rebound following treatment with the antiviral medication Paxlovid -- where infections rev back up again after people complete their five-day course of the medication -- appear to be at least twice as common as doctors previously knew, a new study suggests. Covid-19 rebound also seems …

CNN News AUG. 26, 2022

Covid-19 rebound is probably more common than data suggests, but Paxlovid is still effective | CNN

Some people who take Paxlovid -- and some who don't -- experience a rebound case of Covid-19, with a resurgence of symptoms or positive tests just days after completing treatment and testing negative. Recent cases, including President Joe Biden, Dr. Anthony Fauci and first lady Jill Biden, are …

NIH News Releases OCT. 6, 2022

Findings suggest COVID-19 rebound not caused by impaired immune response

Detailed analysis of eight patients published.